Nanobiotix S.A. announced that it has entered into an agreement with new investor Johnson & Johnson Innovation to issue common shares for the gross proceeds of $25,000,000 on November 1, 2023, The closing of the Global Offering is not conditioned on the closing of the Concurrent Private Placement.
Market Closed -
Other stock markets
|
After market 01:29:56 am | |||
6.37 EUR | +2.58% | 6.373 | +0.05% |
25/04 | Transcript : Nanobiotix S.A., Q4 2023 Earnings Call, Apr 25, 2024 | |
24/04 | Nanobiotix S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.07% | 315M | |
+17.96% | 47.02B | |
+48.77% | 41.86B | |
+1.17% | 41.76B | |
-4.27% | 28.8B | |
+11.42% | 26.05B | |
-21.39% | 19.15B | |
+4.86% | 12.55B | |
+27.29% | 12.34B | |
-3.50% | 11.82B |
- Stock Market
- Equities
- NANO Stock
- News Nanobiotix
- Nanobiotix S.A. announced that it expects to receive $25 million in funding from Johnson & Johnson Innovation - JJDC, Inc.